Petros Pharmaceuticals, Inc. news PTPI
Plain-English coverage of this company’s material 8-K filings — generated from the primary source the moment they file.
← back to Petros Pharmaceuticals, Inc.-
Low Neutral
Petros Pharmaceuticals (PTPI) Separates from Executive Mitchell Arnold
The pharmaceutical company agreed to a severance package with a departing officer, effective June 18, 2026.